Yili Chuanning Biotechnology Co.,Ltd. (SZSE: 301301)
Health Care · Biotechnology · CN
CN¥8.19
+2.12% today · -25.1% 1Y
Yili Chuanning Biotechnology Co.,Ltd. (SZSE: 301301) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.73B.
Over the last twelve months the share price has lost 25.1%, trading between 7.69 and 12.90.
Tweenvest scores Yili Chuanning Biotechnology Co.,Ltd. across four factors: quality 76/100, value 62/100, growth 83/100, dividend 48/100. Its strongest factor is growth.
301301 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.73B
- Revenue (TTM)
- $642.65M
- P/E
- 31.57
- EPS
- 0.26
- Dividend yield
- 2.11%
- Beta (5Y)
- 0.02
- 52-week high
- CN¥12.90
- 52-week low
- CN¥7.69
- Avg volume (3M)
- —
- Shares outstanding
- 2.23B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Keymed Biosciences Inc.SEHK: 2162 | $2.96B | HK$78.85 | +5.20% |
| Sino Biological,Inc.SZSE: 301047 | $2.88B | CN¥159.00 | +8.27% |
| NewAmsterdam Pharma Company N.V.NasdaqGM: NAMS | $2.77B | $22.13 | -4.61% |
| Zai Lab LimitedNasdaqGM: ZLAB | $2.73B | $25.31 | +4.03% |
| BioArctic AB (publ)OM: BIOA B | $2.70B | Skr305.20 | -2.55% |
| BGI Genomics Co., Ltd.SZSE: 300676 | $2.62B | CN¥45.86 | +1.64% |
| Sinocelltech Group LimitedSHSE: 688520 | $2.60B | CN¥37.05 | +3.64% |
| Zealand Pharma A/SCPSE: ZEAL | $2.54B | Dkr249.40 | -0.68% |
Figures last refreshed Oct 4, 2026.